Form 4: Molina Healthcare Director Receives Equity Award
Statement of Changes in Beneficial Ownership
Molina Healthcare, Inc. reports a director, Dale B. Wolf, received an equity award valued at $55,000 on April 1, 2026, as part of his annual compensation.
Summary
- Dale B. Wolf, a Director at Molina Healthcare, Inc., was granted 405 shares of common stock on April 1, 2026.
- This grant is part of the Issuer's 2025 Equity Incentive Plan and is in connection with his services as a Director.
- The annual equity award for each director is set at $220,000, with one quarter ($55,000) granted on the first day of each quarter.
- The number of shares granted is based on the closing price of the Issuer's common stock on the grant date.
- On April 1, 2026, the closing price was $135.82, resulting in the 405-share grant.
- Following this transaction, Mr. Wolf beneficially owns 15,396 shares, held indirectly through the Dale B. Wolf Revocable Trust.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it reports a routine director equity grant and does not contain new financial performance data or strategic shifts.
Positives
- Director compensation structure is clearly defined and transparent, with annual equity awards distributed quarterly.
- The company is utilizing its equity incentive plan to reward directors for their services.
- The grant value is tied to the stock's closing price, aligning director compensation with shareholder value.
Future Outlook
The filing does not contain forward-looking statements or guidance. It reports a completed transaction.
Industry Context
StockSavvy.ai notes that equity awards to directors are a common practice in the healthcare industry to align executive and director interests with those of shareholders and to attract and retain talent.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney | Dale B. Wolf granted a Limited Power of Attorney to Jeff D. Barlow and Codruta Boggs to execute Section 16(a) filings on his behalf. | 03/11/2013 | Ensures timely and accurate filing of ownership changes by authorized representatives. |
Related Party Transactions
- Grant of stock to Director Dale B. Wolf under the Issuer's 2025 Equity Incentive Plan.
Stakeholder Impact
- Shareholders: The equity grant aligns director compensation with stock performance, potentially benefiting shareholders through motivated leadership.
- Employees: The equity incentive plan structure may set a precedent for employee compensation strategies.
- Management: Reinforces the established compensation framework for directors.
Key Dates
| Date | Description |
|---|---|
| 03/11/2013 | Date of execution for the Limited Power of Attorney for Section 16(a) Filings by Dale B. Wolf. |
| 04/01/2026 | Date of transaction: Grant of stock under the Issuer's 2025 Equity Incentive Plan. |
| 04/02/2026 | Date of filing for the Statement of Changes in Beneficial Ownership. |
Keywords
Molina Healthcare, MOH, Form 4, Director Compensation, Equity Award, Stock Grant, Beneficial Ownership, Dale B. Wolf, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.